BRUGNOLI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 727
EU - Europa 199
AS - Asia 82
OC - Oceania 1
SA - Sud America 1
Totale 1.010
Nazione #
US - Stati Uniti d'America 727
IT - Italia 76
CN - Cina 53
GB - Regno Unito 27
TR - Turchia 21
DE - Germania 18
UA - Ucraina 16
BE - Belgio 15
SE - Svezia 14
AT - Austria 10
PL - Polonia 10
VN - Vietnam 6
FI - Finlandia 5
FR - Francia 4
JP - Giappone 2
AU - Australia 1
EC - Ecuador 1
ES - Italia 1
IE - Irlanda 1
NL - Olanda 1
RO - Romania 1
Totale 1.010
Città #
Fairfield 102
Woodbridge 92
Chandler 88
Ann Arbor 68
Ashburn 65
Houston 47
Cambridge 39
Seattle 37
Wilmington 36
Jacksonville 28
Beijing 22
Ferrara 22
Brussels 15
Princeton 14
Izmir 13
Vienna 10
Warsaw 10
Milan 9
Nanjing 9
Morciano Di Romagna 7
San Diego 7
Boardman 6
Dong Ket 6
Shanghai 6
Nanchang 5
Cagliari 4
Cordignano 4
Falls Church 4
Ferrara di Monte Baldo 4
London 4
Shenyang 4
Bremen 3
Des Moines 3
Auburn Hills 2
Changsha 2
Loerrach 2
Monterenzio 2
Muggia 2
New York 2
Norwalk 2
Orange 2
Pozzuoli 2
Redwood City 2
Tianjin 2
Zhengzhou 2
Addison 1
Amsterdam 1
Bordeaux 1
Dearborn 1
Dublin 1
Edinburgh 1
Florence 1
Frankfurt am Main 1
Jiaxing 1
Lappeenranta 1
Los Angeles 1
Melbourne 1
Mountain View 1
New Bedfont 1
Pamplona 1
Philadelphia 1
Prescot 1
Quito 1
San Francisco 1
Sanayi 1
Tappahannock 1
Tokyo 1
Trento 1
Vicenza 1
Washington 1
Totale 842
Nome #
Eltoprazine prevents levodopa-induced dyskinesias by reducing striatal glutamate and direct pathway activity 187
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 143
Safinamide differentially modulates in vivo glutamate and GABA release in the rat hippocampus and basal ganglia 123
Role of LRRK2 in the regulation of dopamine receptor trafficking 114
Genetic deletion of Rhes or pharmacological blockade of mTORC1 prevent striato-nigral neurons activation in levodopa-induced dyskinesia 108
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotics-Induced Weight-Gain. 106
Molecular and imaging prodromal markers of dopamine neuron degeneration in animal models of Parkinson’s disease: pathophysiology and clinical perspectives 44
Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats 41
Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease 38
Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models 37
Safinamide Modulates Striatal Glutamatergic Signaling in a Rat Model of Levodopa-Induced Dyskinesia 33
In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity 29
Novel therapeutic targets in levodopa-induced dyskinesia: in vivo studies in rodent models of Parkinson’s disease 25
Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia 21
Totale 1.049
Categoria #
all - tutte 5.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.033


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201977 0 0 0 0 0 0 0 0 0 0 34 43
2019/2020208 25 9 13 26 16 21 17 18 20 17 17 9
2020/2021221 15 15 10 10 13 8 28 16 13 35 39 19
2021/2022129 3 12 10 3 8 13 11 14 7 12 10 26
2022/2023205 17 33 4 27 27 28 13 13 16 0 18 9
2023/202460 9 4 3 6 6 14 4 12 0 2 0 0
Totale 1.049